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The Zika virus outbreak has captivated the attention of the global audience and information has spread
rapidly and wildly through the internet and other media channels. This virus was first identified in 1947,
when it was isolated from a sentinel rhesus monkey placed by British scientists working at the Yellow
Fever Research Laboratory located in the Zika forest area of Uganda, hence its name, and is transmitted
primarily by the mosquito vector, Aedes aegypti. The fact that the rhesus macaque is an Asian species
being placed in an African forest brings to mind the possibility of rapid adaptation of the virus from an
African to Asian species, an issue that has not been considered. Whether such adaptation has played any
role in acquiring pathogenicity due to cross species transmission remains to be identified. The first
human infection was described in Nigeria in 1954, with only scattered reports of about a dozen human
infections identified over a 50-year period. It was not until 2007 that Zika virus raised its ugly head with
infections noted in three-quarters of the population on the tiny island of Yap located between the
Philippines and Papua New Guinea in the western Pacific Ocean, followed by a major outbreak in French
Polynesia in 2013. The virus remained confined to a narrow equatorial band in Africa and Asia until 2014
when it began to spread eastward, first toward Oceania and then to South America. Since then, millions
of infected individuals have been identified in Brazil, Colombia, Venezuela, including 25 additional
countries in the Americas. While the symptoms associated with Zika virus infection are generally mild,
consisting of fever, maculopapular rash, arthralgia and conjunctivitis, there have been reports of more
severe reactions that are associated with neurological complications. In pregnant women, fetal neuro-
logical complications include brain damage and microcephaly, while in adults there have been several
cases of virus-associated Guillain-Barre syndrome. The virus was until recently believed to only be
transmitted via mosquitoes. But when the Zika virus was isolated from the semen specimens from a
patient in Texas, this provided the basis for the recent report of possible sexual transmission of the Zika
virus. Due to the neurological complications, various vectors for infection as well as the rapid spread
throughout the globe, it has prompted the World Health Organization to issue a global health emergency.
Various governmental organizations have recommended that pregnant women do not travel to countries
where the virus is epidemic, and within the countries affected by the virus, recommendations were
provided for women of childbearing age to delay pregnancy. The overall public health impact of these
above findings highlights the need for a rapid but specific diagnostic test for blood banks worldwide to
identify those infected and for the counseling of women who are pregnant or contemplating pregnancy.
As of this date, there are neither commercially licensed diagnostic tests nor a vaccine. Because cross-
reactivity of the Zika virus with dengue and Chikungunya virus is common, it may pose difficulty in
being able to quickly develop such tests and vaccines. So far the most effective public health measures
include controlling the mosquito populations via insecticides and preventing humans from direct
exposure to mosquitoes.
© 2016 Elsevier Ltd. All rights reserved., Allergy and Clinical Immu-
edicine, 451 Health Sciences
ershwin).1. Introduction
The Zika virus has found its way into the public consciousness,
as it has recently been associated with brain damage in the
offspring of infected pregnant women. The news outlets have
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with information that is both legitimate and misleading. The
internet age has allowed rapid dissemination of such information,
therefore causing rapid reactions or responses by both national and
international agencies, regulatory bodies and professional organi-
zations. The story of the impact the Zika virus has played upon
humanity is an interesting and unique one, which has led to the
government issuing non-traditional recommendations, in an effort
to ensure the public's safety and health. Tracing the sequence of
events from the discovery of the virus to the current state of affairs
provides a useful learning tool that would allow effective responses
during unexpected pandemics. Although there are over 325 pub-
lished articles associated with the Zika virus, the majority coming
out of Uganda, there is still little known about the potential of the
virus [1].
The Zika virus was identified over 50 years ago in Africa where it
is reasoned to have originated. It is known to have spread to various
geographic areas of Asia and the Pacific Islands, with the most
recent spread eastward to the Americas. Earlier, symptoms asso-
ciated with infection included a mild response, which included
fever and fatigue, until this year when it was reported that pregnant
women, primarily Brazilian women, that tested positive with the
Zika virus had fetuses born with brain defects. After Severe Acute
Respiratory Syndrome (SARS), Middle East Respiratory virus
(MERV), the Ebola outbreak, and recurrent re-emergence of mea-
sles, influenza, dengue and cholera throughout the globe, the world
now has a new enemy to contend with, serving as a reminder that
human beings live in a complex relationship with other organisms
in an ecosystem that is often unpredictable [2]. The continuous
encroachment of otherwise forested and/or remote habitats by
humans in search of new space for housing and adventure com-
bined with the ever increasing speed of inter-continental air travel
logarithmically increases the likelihood of the jumping of microbial
species from its natural habitat to urban locations. This is a reality
to be faced by those involved in public health safety andwill remain
a continuing challenge to health care providers worldwide.
2. History
Several viruses were reported to have been isolated by a team of
British and American scientists that were in charge of the Yellow
Fever Virus Research Institute housed in Entebbe, Uganda during
the late 1930's to late 1940's primarily with the aim of isolating
yellow fever viruses (YFV) [3]. In efforts to isolate the YFV, these
scientists placed Asian species rhesus macaques (Macaca mulatta)
in sentinel cages atop forest canopy level platforms in the Zika
Forest area located near Entebbe, Uganda, presumably in a location
where they could serve as potential hosts for the local mosquito
population known to be vectors of the YFV. Blood samples isolated
from one of these “sentinel” rhesus macaques (monkey 766) when
injected into the brains of Swiss albino mice led to sickness of these
mice. Homogenates of brain tissues from these sick mice led to the
isolation of several filterable viruses, amongst one that was called
the Zika virus766 because of the forest and the number of the
monkey (hence, its name) [4,5]. These viruses were also isolated
from mosquito populations from the same location and thus
reasoned to be circulating and being kept endemic by virus host
interactions between the indigenous monkey species (that include
13 species with the colobus species monkey being predominant)
andmosquitoes. The fact that the virus was isolated from “sentinel”
Asian rhesus macaques implies that there must have been an
adaptation of the virus from the African monkey species to the
Asian monkey species (jumping of species). Whether such adap-
tation was instrumental in further transmission of this virus and
whether such adaptation led to increased pathogenicity remainsunknown. It should be noted that sera collected from blood sam-
ples of several local individuals residing in the same area during the
same time period were found to contain antibodies against the Zika
virus presumably suggesting that the virus was already circulating
in the human population. However, there were no reports of any
disease. What is not clear is the specificity of the antibody test that
was utilized at the time since there is considerable cross reactivity
among the flaviviruses. It was first isolated from a human in 1969 in
Nigeria, though the illness caused by the virus, Zika fever or Zika
disease has been known to infect humans since the early 1950s [6].
A time line of the history of the Zika virus is shown in Fig. 1; the
countries involved are shown in Table 1.
Early reports of the Zika virus identified very rare cases of hu-
man disease. Lanciotti stated in a 2008 review that “Historically,
Zika has rarely been associated with human disease” [7]. Early re-
ports of epidemics were reported primarily in the South Pacific and
in Southeast Asia. The Yap Island reported 185 cases of probably
Zika infection and a seropositivity rate of greater than 74% of the
population in 2007.
3. Biology of the Zika virus
3.1. Classification
The Zika virus belongs to the family Flaviviridae and the genus
Flavivirus. Other Flaviviruses include yellow fever, dengue, West
Nile and Japanese encephalitis viruses [8,9]. Flaviviruses belong to a
group of viruses labeled as “arborviruses”, which is a descriptive
term that refers to hundreds of RNA viruses which rely on arthro-
pods such as mosquitoes or ticks for transmission. Arboviruses
(arthropod borne viruses) cause some of the most devastating
diseases in humans and animals worldwide. The families of RNA
arboviruses include Bunyaviridae, Flaviviridae, Reoviridae, Rhab-
doviridae, and Togoviridae. The arboviruses are acquired orally by
their hematogenous vectors in the form of a blood meal of an
infected vertebrate host. These viruses are non-pathogenic to the
vector but have to be able to survive in a live form in the vector
which then transmits via saliva deposition into a new vertebrate
host. This cycle is important to remember since the details of how
the virus survives in the vector host and whether it replicates in the
vector host, and if it replicates, the cell types that it infects in the
vector and whether the virus changes in any form in the vector host
(such as glycosylation of its envelope for example) are all important
issues that influence the ability of the vector to transmit infection
including the Zika virus. Evidence for recombination of the virus
has already been documented to have potentially occurred by
transmission of the virus via a different species of mosquitoes [10].
The Zika virus is closely related to the Spondweni virus. There are a
total of seven groups of mosquito-borne flaviviruses, according to
the International Committee on Taxonomy of Viruses (ICTV). The
groups are categorized based on antigenic and genetic consider-
ations. The genus Flavivirus consists of 39 different mosquito-borne
viruses [11].
3.2. Structure of the Zika virus
The Zika virus is composed of a positive sense, single strand RNA
genome. It is an enveloped, icosahedral virus that is a member of
the Spondweni clade. The Zika virus is a positive polarity RNA virus
with a genomic size of about 11 kb [12]. The single open reading
frame sequence of its RNA genome encodes a polyprotein which
constitutes the structural architecture of the virus [13]. This poly-
protein contains 3 components, including a capsid (105 aa),
membrane and premembrane portion (187 aa) termed C, M and P,
respectively. There is also an envelope protein (E, 505 aa) and an
Fig. 1. Zika virus spread patterns and Aedes mosquito global distribution.
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proteins are designated NS1 (352 aa), NS2a (217 aa), ND2b (139 aa),
NS3 (619 aa), NS4a (127 aa), NS4b (255 aa) and NS5 904 aa) [14].
The non-structural proteins NS2B/NS3 includes a serine protease
that along with host proteases co-translationally and post-
translation cleaves the polyprotein into its components. The en-
velope protein is the primary flavivirus antigenic site and dictates
attachment of the virion and penetration into the host cell. Folding
of the E protein is controlled by the premembrane protein, which is
cleaved by furin to form the membrane protein prior to mature
virion release from the cell [15]. The function of the remaining non-
structural proteins remain unknown, but may have specific
essential roles in various replication stages. For example, NS5, the
most highly conserved of the flavivirus NS proteins functions as a
RNA-dependent RNA polymerase [16].
3.3. Zika virus genome
There are two known lineages of the Zika virus, an African
lineage and an Asian lineage [17]. These are distinguishable by
detailed genetic analysis of the RNA sequence [18]. The primary
variability when comparing strains appears to be related to differ-
ences in the availability of potential glycosylation sites. The com-
plete coding sequence of the virus obtained from a patient from
French Polynesia who was hospitalized after falling ill in metro-
politan France revealed an Asian lineage, with 99.9% nucleotide and
amino acid homologywith isolates that circulated during the 2000s
in Southern Asia and the Pacific Islands. It is believed that the Asian
lineagewas introduced to Asia from Africa as early as 1945 [14]. The
Zika virus isolated from another two patients hospitalized in French
Polynesia was also subject to phylogenetic analysis and found to be
of Asian lineage [19].
Five patients with mild symptoms of Zika virus infection were
identified from Suriname in October 2015. The sera of 4 of the
viremic patients were submitted for genomic sequencing [20]. Thecomplete coding sequence was obtained from one patient and the
genome of the envelope protein was determined from the other
three. The genome sequence from the Suriname patients is
considered to be of the Asian genotype, as opposed to the African
lineage. As with most epidemiological studies, the complete
sequencing of the Zika virus genome has been rarely done, but the
Suriname genotype shows over 99% protein and gene homology
with the strain isolated from French Polynesia in 2013.
Sequencing of a 976 base pair region of the NS5 gene in 51 pa-
tients from the Easter Island outbreak revealed that phylogeneti-
cally, the strains from Easter Island were very closely related to the
strains from French Polynesia, Cambodia and Micronesia, all from
the Asian lineage [21]. In contrast, there were three Zika virus
isolates from Sylvatic mosquitoes in the Central African Republic
which demonstrated 99.9% and 100% nucleic acid sequence and
amino acid sequence homology with each other respectively, but
which differed from other Zika strains. This led the authors of this
study to conclude that while these virus strains evolved from an
African lineage, there exists a different West African Zika virus
subtype in Central Africa from the African strains found in other
countries such as Gabon [22].
It is unclear why Zika has suddenly evolved into a global
pandemic. There is an extra 12 nucleotide sequence in the envelope
gene discovered in the virus that led to the Yap Island epidemic in
2007, which was not present in the prototype MR766 Zika virus [7].
This 4 amino acid sequence corresponds to the 154 glycosylation
motif in the envelope protein that may play a role in virulence.
More research is necessary to clarify the role of glycosylation in the
pathogenesis of Zika virus infection.
4. Geographical spread and distribution of the Zika virus
It is generally accepted that Zika virus originated in Africa and
then likely spread in two directions. Thus, there were cases re-
ported in various parts of Africa that included one in Nigeria in
Table 1
Countries with reported Zika virus infection (as of Feb 2016).
Country Continent First infection
reported
Number of cases Associated illnesses References
Australia Australia 2015 Case report following monkey bite, import from Cook Island, case report after
travel to Indonesia
Unknown [111e113]
Brazil South
America
2015 440,000e1,300,000 4000 microcephaly
cases
[114]
Cambodia Asia 2010 Case report None [115]
Canada North
America
2013 Case report of transmission from Thailand Unknown [40]
Colombia South
America
2015 578 RT-PCR confirmed cases as of Nov 28, 2015 [116]
Easter Island South
America
2014 89þ samples Unknown [21]
El Salvador Central
America
Federated States of
Micronesia
Asia 2007 70% of population [7,17,114]
French Polynesia 2013e14 [71,117]
Germany Europe 2013, 2014 Transmission in traveler from Malaysian Borneo, and in a traveler from
Thailand
Unknown [44,118]
Indonesia Asia 1977 7 cases Unknown [7,119]
Italy Europe 2015 Case report of patient from Brazil and French Polynesia e not autochthonous Unknown [120,121]
Jamaica Central
America
Japan Asia 2013e2014 2 cases imported from French Polynesia Unknown [122]
Maldives Asia June 2015 Case report [123]
New Caledonia Asia 2014 2 patients with co-infection with dengue Unknown [73]
Nigeria Africa 1954 First human infection case, additional cases in 1971e5 Unknown [3,124]
Norway Europe 2013 Following travel to Tahiti Unknown [125]
Philippines Asia 2012 Case report of a 15 year old boy Unknown [126]
Solomon Islands
Suriname South
America
Thailand Asia 2012e2014 7 cases Unknown [127]
USA North
America
2015 Cases in New York and Texas, now 31 confirmed cases [128,129]
Vanautu Asia 2014 2 cases Unknown [73]
Venezuela South
America
2015 [130]
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Verde Island. The other route of spread was Eastward to the Pacific
Islands and Asia. Multiple arbovirus infections were reported in the
late 1950s and early 1960s in East Africa, including Zika, yellow
fever, Banzi, Wesselsbron, West Nile and dengue 1 (group-B arbo-
viruses), chickungunya, o'nyong-yong and Sinbis (group-A arbovi-
ruses), and Bunyamwera virus [23]. Although known since 1947,
extensive spread of the Zika virus to Asia probably only occurred as
recently as 2012e2014 [24]. It is unknown what triggered the
worldwide emergence of a disease confined to a narrow tropical
band. RT-PCR based studies on the Zika virus suggest that genetic
changes in protein glycosylation through recombination events
may have led to a higher efficiency in transmission via mosquito
vectors, thus facilitating changes in geographical spread patterns
[10].
Health emergencies in the Pacific region are dealt with by the
Pacific Public Health Surveillance Network (PPHSN), a voluntary
network of 22 Pacific Island countries which are home to 10.6
million people. The network noted that beginning in January 2012,
there was a sudden increase in mosquito-borne diseases including
dengue, chikungunya and Zika virus. The network identified over
the next 2 years a total of 28 separate outbreaks and a circulation of
several mosquito-borne diseases. By 2014, a total of 120,000 people
were infected, which was believed to be a conservative estimate
due to underreporting [19,25].
The first reports of Zika virus in Brazil appeared in May of 2015
[26,27]. Prior to April of 2015, Zika virus was non-existent in Brazil.
The first case of autochthonous transmission of the virus in Brazilwas reported in March of 2015 [28]. The increased incidence of
microcephaly in infants born in Brazil led to the realization that
there is an extremely likely association between brain damage and
Zika virus infection, though even to this day this has not yet been
definitively confirmed [8,29]. In barely eight months, there have
been over 4000 confirmed cases of microcephaly in Brazil, ac-
cording to a report in the British Medical Journal published on the
26th of January, 2016 [30]. The virus is widespread in multiple re-
gions and states in Brazil [31e33], and the reports of microcephaly
coincide temporally with the appearance of the Zika virus in Brazil.
Other Latin American countries have since reported cases of Zika
virus infection [34,35]. Tracing the route of spread, one theory is
that the beginning of the disease in Brazil was caused by trans-
mission from the outbreak in French Polynesia in 2014, which
coincided with the World Cup football competition [36,37]. In
addition, it has been proposed that climate changes may have
facilitated the spread of Zika virus to the Americas by virtue of the
warmer temperatures and drought conditions observed in the
second half of 2015 in South America. Drier conditions may have
enhanced vector dispersal [38].
A recent case of Zika virus was diagnosed in Japan in a patient
who had traveled from Thailand. In this case, Zika virus infection
was diagnosed by RT-PCR in the urine. The sera from this patient
also had IgM cross reactivity with the dengue virus. This illustrates
the need to be able to distinguish Zika virus from dengue and other
flaviviruses [39].
One case report of a patient from Canada was found in the
literature [40]. This report describes a patient who acquired the
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in North America [41]. The Aedes aegypti is not widely found in
Canada, so it has been reasoned that Canada is not at risk for an
epidemic, although the recent reports of sexual transmission may
alter this viewpoint.
There is a suggestion that the Zika virus may follow the
migration patterns of the Chikungunya virus, an alpha virus which
is also transmitted by mosquitoes [42]. Chikungunya virus belongs
to the group IV Togaviridae arbovirus family. All alphaviruses are
single strand positive sense RNA viruses that possess a nucleo-
capsid. Interestingly, the mosquito vectors for both these viruses
have adapted to be active during the daytime and thrive in urban
areas.
It is believed that since 1947, when the virus was first identified,
it remained obscure and confined to an equatorial belt in Africa and
Asia. The spread of the Zika virus was analyzed in a communication
published in the Lancet, based on local and regional travel patterns
and climate considerations. The spread to neighboring 13 countries
was consistent with travel volume and may provide important in-
formation related to the upcoming Olympic Games in Rio de Janiero
[43].
Numerous cases of Zika virus detectable in travelers returning
from epidemic areas have been reported. It has been detected in
multiple travelers in Europe, including Germany, France and Italy.
Serological studies from German tourist travelers showed both IgG
and IgM positivity to the ZIka virus upon return from Thailand [44].
In addition, some have speculated that El Nino has played an
important role in the spread of Zika in Latin American countries as
the phenomenon could help create the ideal conditions for the
proliferation of mosquitoes. “El Nino”, characterized by a warming
of the central and eastern Pacific Ocean near the equator, is known
to change rainfall patterns around the world, including Latin
America.
5. Transmission of the Zika virus
5.1. General comment
The transmission of arboviruses by definition involve an
arthopod borne vector (mainly species ofmosquitoes and ticks) and
a vertebrate host. It is reasoned that most of these arboviruses
remain endemic in tropical and sub-tropical areas of the world that
promote the life cycle of the arthropod. Inmost, if not all such cases,
the virus in question does not cause any disease in its natural host.
Thus, the infectious virus has to be present in sufficient quantity in
the blood/tissues of the vertebrate host so that it is picked up by the
arthropod when it bites the natural host. The infectious virus then
has to survive in the arthropod and in some cases replicate in a
specific tissue of the arthropod and once again be in sufficient in-
fectious amounts to be delivered by the arthropod to another
natural host to continue the cycle. Mosquitoes generally feed on
plant nectars and it is primarily the female mosquito that feeds on
vertebrate blood that is needed for the maturation of the eggs it
carries. The average life span of a male mosquito is only 10 days and
1e2 months for the female and the range of a mosquito is
1e3 miles. Thus, female mosquitoes have to be transmission
competent within this framework for the life cycle of the arbovirus
to be complete. One study reported survival of the Zika virus for a
period of two weeks in female mosquitoes, suggesting the stability
of the virus in the vector host. As one may gather, these are rather
stringent requirements for the life cycle of arboviruses and have
evolved over millennia. It also seems clear that it is only when such
viruses jump species (non-natural host), i.e. to humans, that we see
evidence of disease often with serious pathology and, in a small
number of cases, potential death of the host.5.2. The Aedes mosquito
Arboviruses are obviously generally more prominent in tropical
climates where the mosquito species thrive. They have the capa-
bility of undergoing explosive spread and a significant proportion
of the population can be infected over weeks to months [45]. The
Zika virus is spread by mosquitoes belonging to the Aedes species
[46]. In the Uganda forest which is the namesake of the Zika virus,
mosquito population analysis revealed a total of 58 species. The
mosquito species diversity is changing, asmosquito populations are
constantly being monitored, and 22 of the 58 species were
considered new to the Zika forest, and 20 previously detected
species were no longer found at the time of this study. Of the 58
species detected in 2014, the majority belonged to the genera Aedes
and Culex [47]. Changing biodiversity is influenced by human ac-
tivity (building roads, communities, hunting, agricultural in-
cursions, and timber harvesting) and changing climate [48].
In particular, the A. aegypti mosquito is known to be the pre-
dominant carrier for Zika virus infection [49]. This is the same
mosquito that spreads the yellow fever virus. This mosquito can
breed in small quantities of water, and is known to be active and
aggressive during the daytime hours, but especially during dusk or
dawn in cloudy weather, and often indoors. This mosquito origi-
nated in Africa, but now can be found in almost all subtropical and
tropical climates throughout the globe. Zika virus was isolated from
the A. aegyptimosquito in Malaysia in 1969 [50]. In North America,
the A. aegypti species are found primarily in Florida, but they have
also been detected as far north as Washington, DC. The A. aegypti
mosquito lives for 2e4 weeks, but its eggs can survive for long
periods of time in a dry state, and are known to reintroduce large
numbers of the mosquito after a cold, dry winter. Other diseases
that are transmitted by the A. aegypti mosquito include dengue,
yellow fever and chikungunya. A. aegypti has been identified to be
the main vector for arboviruses in the Pacific region [51]. In Brazil,
where recent Zika virus cases have exploded, the A. aegypti mos-
quito had been known for its ability to transmit related virus such
as dengue or Chikungunya [52].
Another mosquito that has been known to transmit the Zika
virus is Aedes albopictus, the Asian tiger mosquito [53]. A. albopictus
was believed to play a role in the Zika virus epidemic in Gabon in
2007 [54]. Because A. albopictus is present in Southern Europe, the
WHO issued a warning to European countries to be on the lookout
for potential cases of Zika infection [55]. An analysis of the trans-
mission potential for the Zika virus by various species of the Aedes
mosquito was conducted [56]. A. aegypti, A. albopictus, Aedes uni-
lineatus and Aedes vittatus were all found to be susceptible to Zika
virus infection. Interestingly, in this study performed in Senegal, A.
aegyptiwas found to have low potential for transmission of the Zika
virus, which was discordant with other findings from other studies
and field observations [57]. Studies designed to define the range of
vector species employed the use of murine skin explants that
served as a barrier when placed on Zika virus heparinized human
blood and the candidate mosquito species allowed to feed on such
an in vitro culture system. The Aedes spp of mosquitoes were found
to be easily infectable with the Zika virus using this technique [58].
Zika virus has also been isolated from Aedes africanus in the Lunyo
forest on the shore of the Entebbe peninsula as early as 1948 [59],
and was again isolated from this strain of Aedes mosquitos caught
from various heights of a 120 m tower in the Zika forest in Uganda
in the early 1960s [60].
An early outbreak of the Zika virus in the Pacific Ocean can be
traced to the case of French Polynesians who attended a cultural
event on Easter Island, Chile. This may represent the path by which
the Zika virus was introduced into the Americas from Asia [36]. The
initial spread was slow, but once it appeared in South America, its
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Americas [61].
In 2011, a large number of mosquito pools collected in Senegal
between April and December were tested for Zika virus infection.
Of a total of 1700 of these mosquito pools, 31 were positive for the
Zika virus. The mosquitoes species found included A. aegypti, Aedes
furcifer, Aedes luteocephalus, A. vittatus, A. africanus, Aedes dalzieli,
Aedes hirsutus, Aedes taylori, Aedes metallicus, Aedes unilinaetus, and
three other non-Aedes mosquito strains [57]. The A. furcifer males
and A. vittatus were two species that were found to be infected in
one of the villages and are most likely the vectors in this
geographical locale. On the other side of the globe, a Zika epidemic
was reported on the Cape Verde islands in the Atlantic Ocean, with
4744 reported cases as of December 6th, 2015 [62]. The Aedes
hensilli species of mosquitoes was shown to be the likely vectors of
Zika infection in this outbreak [63].
It has to be kept in mind that the transmission potential of the
vector being evaluated is not the only factor in determining the role
such a vector plays in the extent of a viral outbreak. This concept is
highlighted by the finding of high density but low transmission
potential of A. aegypti serving as a successful vector for the spread
of yellow fever in Nigeria [64].
5.3. Non-mosquito transmission
The natural transmission cycle of arboviruses, in general, have
been thought to involve mosquitoes. However, there have been
reports of perinatal transmission of the Zika virus [65], and po-
tential risk for transfusion related transmission of Zika virus has
also been documented [66]. In addition, Foy et al. [67] has reported
sexual transmission of the Zika virus to the wife of a patient who
got infected in Senegal after his return to the US. The transmission
was reasoned to be via semen but the semenwas not tested. In this
regard, it is important to note that Flaviviruses have been detected
in urine samples of individuals infected with the West Nile virus
with suggestive evidence that the virus was in fact replicating in
these patients and being shed and thus thought to be infectious
[68]. Similarly dengue virus RNA and non-structural protein of the
dengue virus (NS1) has also been reported in urine samples of
infected patients, but in vitro culture of the urine sample failed to
show any evidence of replication competent virus. Finally, yellow
fever virus RNA was shown to be present in the urine of a vacci-
nated individual [69]. More recently a case of sexual transmission of
the Zika virus in Texas has been reported raising considerable
concern among the public health officials in the state and at the
CDC, Atlanta, GA. This was based on the isolation of Zika virus in the
blood of a non-traveler who had sexual contact with a partner who
had recently returned from Venezuela.
As with most infectious diseases, once the etiological agent has
been identified in a given region, the agencies of the government
such as the FDA and the CDC rapidly step in to include a require-
ment for testing of blood, organ and tissue donors for the suspected
agent within the region. This was certainly the case with the dis-
covery of cases of the West Nile virus in patients that had received
blood transfusions from a specific blood center in New York during
2002. The CDC rapidly required a study of the blood donors
involved and upon finding positive links between blood donors and
transmission of WNV, have implemented PCR based tests to keep
the blood supply safe [70]. There have been a series of studies
conducted by blood donor centers including the Red Cross to
determine the potential of setting up screening assays for viruses
such as dengue, particularly in geographic areas that are eyed with
a high degree of suspicion for the presence of dengue, such as
Puerto Rico. These studies continue to this date and should result in
critical recommendations (Table 2).There are now a series of guidelines issued by the FDA that re-
quires blood banks to follow strict rules for declaring a blood
sample safe for transfusion. Examples of studies of screening of
blood donors for Zika virus include the detection by PCR based
assays of 42 positive samples out of a total of 1505 asymptomatic
blood donors in French Polynesia [66]. Other reports of non-
arthropod transmission have surfaced as well, in the form of
contaminated semen in a patient in Tahiti [71], and one case in
Colorado [67,72], or through blood transfusions in French Polynesia
[66].
5.4. Vertical transmission of the Zika virus
Due to the potential link between microcephaly and Zika virus
in pregnant women, the ability of Zika virus to be transmitted via
the perinatal route is of significant interest and critical concern. A
study in 2014 evaluated Zika virus in the serum of mother and
newborns during delivery. Two such cases from French Polynesia
were studied, and it was found that Zika virus RNA could be
detected in the serum of the mother up to 5 days post-partum and
in the newborn up to 6 days. Zika virus was also detected in the
breast milk of the mothers. This finding needs to be confirmed in
larger studies, but opens the possibility of transmission via the
perinatal or post-delivery through nursing [65].
Overall though, with millions of cases of dengue and West Nile
virus infections and other arthropod borne illnesses, there is very
limited evidence for sexual transmission of arboviruses and thus it
seems unusual to observe sexual transmission of the Zika virus. If
borne out via larger studies, it would indicate that either the levels
of viremia are significantly higher for Zika virus than the other
arboviruses so that it can spill over to many body fluids including
semen or the target cell population(s) of the Zika virus is distinct
from the other arboviruses. The precise cell lineages targeted by
arboviruses in vivo has been a subject of considerable debate over
the last four decades. Further studies are clearly required to address
these issues.
6. Clinical manifestation of Zika virus disease
Most infections caused by the Zika virus are asymptomatic
(approximately 80%). The most common symptoms are fever, rash,
arthralgias and non-purulent conjunctivitis. In 2007, a Zika
outbreak in Yap Island in the Federated States of Micronesia,
myalgia, edema and vomiting were also reported [17]. The incu-
bation period of Zika virus is unknown but if similar to other fla-
vivirus infections, is estimated to be between 3 and 7 days. Dengue
and Chikungunya often have a similar but not identical presenta-
tion, and co-infection with these viruses has also been described in
at least two case reports [73,74].
While there are similarities between dengue and Zika virus
infection, there are some notable differences [75]. First of all,
dengue infection is caused by four different serological types of
dengue virus termed DEN 1, 2, 3 and 4. Infection with one type
leads to life long immunity against the same type. However,
exposure of the individual to a second type of dengue virus, in a
small number of cases leads to a very severe form of illness
resulting in shock and hemorrhage termed dengue shock syndrome
and dengue hemorrhagic fever. This has not so far been reported for
the Zika virus infections. The fever in dengue virus tends to be
higher (>40 C versus <38.5 C). Nausea and vomiting can be a
significant symptom in dengue virus. Headaches, retro-orbital pain
and joint symptoms may occur in both infections. As indicated, in
most cases, particularly in endemic countries, dengue infection is
benign and limited to fever during the acute phase followed by a
gradual return to normal. In the few cases with exposure to a
Table 2
Public health measures taken since the spread of the Zika virus.
Content of release Country/Agency or
release
Type of
release
Content Reference Comments
Take precautions against mosquito bites WHO [30]
Postpone pregnancy Jamaica, El Salvador,
Brazil
Advisory Avoid pregnancy for 6e12 months, or up
to 2 years
[30,131]
Pregnant women should postpone travel to countries with Zika
virus infection
United States, United
Kingdom
Advisory Travel advisory to Brazil and other areas [30,132]
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phases of disease: an acute febrile phase, a critical (plasma leak)
phase where hematologic abnormalities, shock and death can
occur, and a recovery phase. In Zika infections, the course is about
2e7 days and it is self-limiting. Secondary dengue infection often
requires hospitalization and 2.5% of infected individuals will
develop a lethal illness, but in Zika virus infections, most cases are
managed on an outpatient basis. Non-steroidal anti-inflammatory
drugs (NSAIDS) can increase risk of bleeding in dengue, but are
acceptable to use in Zika virus infection as long as dengue has been
ruled out. Long term sequellae may persist in dengue infection for
up to 2 years, while none have been associated with Zika virus
infection in the primary host (i.e. not including fetal losses and
complications in offspring). There may be an association with
Guillain-Barre syndrome in Zika infection [76]; this association has
also been observed in dengue infection [77]. Laboratory findings in
Zika virus infection include leukopenia, thrombocytopenia,
elevated serum lactate dehydrogenase, gamma-glutamyl trans-
ferase and increased levels of inflammatory markers such as C-
reactive protein, fibrinogen and ferritin [3,44].6.1. Pregnancy, microcephaly and the Zika virus
The detection of Zika virus is one of the keys to formally define a
definite link between Zika virus infection and microcephaly. Thus,
previously serological tests have been performed for the detection
of antibodies. However, it is generally known that there is consid-
erable cross reactivity between the various flaviviruses and thus the
specificity of the test becomes an issue. There have also been plaque
reduction neutralization (PRNT) tests performed but the problem
with such assays is that the presence of antibodies in the newborn
could be due to passively transferred neutralizing antibodies from
the mother, making it difficult to distinguish infection of the baby/
fetus. The more recently developed PCR assay can obviously be
performed and yield valuable information. However, if the fetus
was infected in utero with neurological sequellae including
microcephaly, the period of viremia may have passed and thus
negative findings may not be informative. Thus, there are clear
challenges. These challenges are highlighted by the findings of the
recent outbreak in Brazil. The latest data from the Ministry of
Health, Brazil, shows that there were 4180 reported cases of
microcephaly associated with Zika virus infection. Of these 4180
cases, 732 (17.5%) have been investigated and classified. Of the 732
classified cases 270 were confirmed to have neurological manifes-
tations but only six of these 270 cases were found to be positive for
Zika virus. These findings have to be interpreted with caution as
outlined above. There have been no reported cases of microcephaly
from Southeast Asia (could be due to lack of clinical awareness) but
the outbreak in French Polynesia in 2013 and earlier in Brazil both
did report associations of Zika virus infections with neurological
complications such as Guillain Barre syndrome (GBS). It is clear
therefore considerable challenges lie ahead in establishing a cause
and effect and the mechanism of Zika virus infection and micro-
cephaly. A case control study would be one answer.7. GBS and the Zika virus
The National IHR Focal Point of El Salvador reported a spike in
the number of cases of GBS between the 1st of December 2015 and
the 6th of January 2016. Normally, there are an average of 169 cases
per annum in El Salvador, but in this short period there were 46
cases and 2 deaths reported. Zika-virus associated GBS, as stated
above, has also been reported in French Polynesia [78]. The first
case observed in December 2013 was published in March 2014 [76].
Subsequently, additional cases of GBS were identified, and the
incidence was 20-fold higher than expected during the time coin-
ciding with the Zika virus epidemic in French Polynesia [79]. GBS
has been of significant interest to immunologists for decades
because of the potential for disease induction via molecular mim-
icry; molecular mimicry has been a theme for induction of other
autoimmune diseases as well [80e82].
8. Diagnosis of Zika virus infection
The diagnosis of Zika virus infections has been a challenge.
Murine monoclonal antibodies which are specific to the viral en-
velope glycoprotein and NS1 glycoprotein fromWest Nile virus and
yellow fever virus were tested against the C1008 cell line experi-
mentally infected with the Zika and Langat viruses. The Mab541
andMab109 clones against the viral envelope glycoprotein and NS1
glycoprotein, respectively, were shown to stain the nucleus of Zika
virus infected cells and the nucleoli of Langat virus infected cells,
respectively but not the cytoplasm [83]. These findings first of all
highlight the problems of cross reactivity between the various
flaviviruses and secondly, that nuclear and nucleoli localization are
difficult to interpret. Early development of testing for flavivirus
infection involved the use of solid-phase immunosorbent tech-
niques and hemagglutination-inhibition assays to detect the IgM
isotype against specific viruses, especially during primary acute
infection [84]. There have also been plaque reduction neutralization
assays (PRNT) performed. However, much like the problems with
the diagnosis of other flaviviruses such as dengue and yellow fever,
the issue of specificity and cross reactivity remain and need to be
addressed. Besides these serological assays, the assay of choice at
present is the Reverse Transcriptase-Polymerase Chain Reaction
(RT-PCR). False positives due to cross-reactivity represent a major
challenge. The presence of nucleic acids in body fluids may not be
persistent enough to accurately diagnose patients with active
infection. There are no commercially available tests, and Zika
testing is currently only performed at the CDC laboratory and at
some state and regional health departments [85].
8.1. RT-PCR
The entire Zika ss(þ) RNA genome consists of 10,794 nucleo-
tides. Full length genomic sequencing of the Zika virus was
accomplished in 2006 [86]. RT-PCR methods for the rapid detection
and identification of flaviviruses, including Zika virus, were estab-
lished as early as 1994 [87]. Original primers were derived from
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region. In 2008, an RT-PCR protocol utilizing sequences encoding
the envelope protein regionwas developed. The detection limit was
7.7 pfu/reaction and the methodology was determined to be 100%
sensitive in serum and specific by its failure to amplify genomes of
19 other flaviviruses [88]. In subsequent studies, polymerase chain
reaction assays for Zika virus have mostly targeted the NS5 gene.
The NS5 gene is chosen for primer development because this region
displays a high degree of conservation among flaviviruses, while
envelope protein genesmay vary within a single flavivirus and thus
present false negative data [89]. In a separate study, real time
reverse transcriptase PCR (rRT-PCR) offers a quick and quantitative
method to detect and evaluate the presence of Zika virus in
mosquitoes. A method utilizing the NS5 protein coding regions was
found to show high sensitivity for 37 Zika virus strains and speci-
ficity against other flavivirus strains. At the time of the study, this
methodology had been tested on field mosquitoes and not yet
applied for clinical diagnostic usage [90].
It is currently recommended that RT-PCR testing be done within
the first 6 days of the onset of illness. It is also believed that in the
early phases of the disease, the virus is present in its highest con-
centrations in the saliva, but that presence can be more persistent
in the urine [91], thus testing should be done from one of these two
specimens. In a study of 855 patients presenting with symptoms of
Zika virus infection, investigators in French Polynesia analyzed
1067 samples from saliva, blood or both sources. In 182 patients
from whom both urine and saliva samples were available, there
were 35 that were saliva positive, blood negative and 16 of which
were saliva negative, blood positive. The timing of obtaining the
samples revealed no pattern with regard to saliva versus urine
positivity [92]. A separate study found the presence of Zika virus in
the urine of 6 patients greater than 10 days after onset of symptoms
[91].
8.2. Enzyme linked immunosorbent assay (ELISA)
IgG and IgM titers to Zika virus can be obtained. False positive
rates are higher in patients who live in countries inwhich flavivirus
such as dengue is prevalent denoting exposure to a flavivirus. Pla-
que reduction neutralization testing (PRNT) is useful to differen-
tiate between cross-reacting antibodies. One study from
investigators in French Polynesia and France investigated the
prevalence of seropositivity to various related arboviruses between
2011 and 2013. Overall, samples from 593 donors were obtained
and were analyzed for IgG antibodies against Zika, Japanese en-
cephalitis virus (JEV), West Nile virus (WNV), and four dengue vi-
ruses. Recombinant antigens composed of domain III of the
envelope glycoprotein was used in these ELISA tests. Overall sero-
positivity rates were 0.8% for the Zika virus, 1.3% for JEV, 1.5% for
WNV and 80.3% for at least one of the four dengue virus serotypes
[93].
9. Pathogenesis of Zika virus infections
The pathogenic mechanisms that lead to potential fetal abnor-
malities by Zika virus infections is unknown. It has been postulated
that Zika related arboviruses such as the dengue virus or the Chi-
kungunya virus may act through the induction of an autophagic
response in infected cells [52]. Autophagosomes were shown to
contain poliovirus particles in patients infected by the polio virus.
The mechanisms by which viruses use autophagy to infect cells
varies amongst viruses. For example, the dengue virus is able to
reorganize membranes to form autophagosomes which can fuse
with endosomes to form amphisomes. The dengue virus then is
able to replicate inside these double membrane vesicles that areinduced by the virus. A similar event is thought to occur with Zika
viruses, but this has not been well characterized [94]. Flaviviruses
including the Zika virus have been found to activate the unfolded
protein response (UPR), which may play a role in autophagy which
is linked to alterations in the function or degradation of endo-
plasmic reticulum architecture or composition [95].
To further characterize the role of Zika virus in microcephaly, it
has been shown that microcephaly may be related to the abnormal
function of centrosomes. Centrosomes are organelles that serve as
the primary microtubule organizing centers of an animal cell. They
have a role in mitosis and vesicle migration, polarization and traf-
ficking. It has been demonstrated that increased centrosome
number has been associated with microcephaly. It is not known if
the Zika virus plays a direct role in centrosome development, but
certain proteins have roles in both autophagy and centrosome
development [96]. An increase in centrosome number can cause a
delay in mitosis and an increase in apoptosis. This can lead to ab-
normalities in neural cell development and a consequence of this
may be a reduction in brain matter formation or microcephaly [97].
Animal studies have shown that Zika virus leads to enlargement
of astroglial cells and destruction of pyriform cells of Ammon's horn
in newborn and 5-week old mice [98]. The virus is able to replicate
in neuronal cells and is found within the endoplasmic reticulum.
The significance of this finding on Zika virus associated micro-
cephaly in human newborns remains unknown. The early studies
on the effect of Zika virus in mice also demonstrated their presence
in the central nervous system, but not in other tissues at the onset
of illness. Intracerebral inoculation of guinea pigs, rabbits, and
cotton-rats failed to induce clinical infection. Physical signs of
infection (pyrexia) was inducible in Rhesus monkeys following
subcutaneous inoculation with Zika virus [4,99].
9.1. Cytokine profiles in Zika infection
An analysis of cytokine levels was performed on plasma samples
from a very small set of patients with active and convalescent Zika
infection from Southeast Asia, Brazil or Polynesia. The subjects had
a history of travel to Thailand, Tahiti, Malaysia or Brazil. Levels of
pro-inflammatory cytokines, IL-1b and IL6 were elevated in sam-
ples from the acute phase, as were levels of IL-2, IL-4, IL-9, IL-10, IL-
13 and IL-17. Increases in the levels of most of these cytokines
persisted into the recovery phase, but granulocyte-macrophage
colony stimulating factor (GM-CSF) and fibroblast growth factor
(FGF), and IL-8 were also elevated during this recovery phase.
Interferon-g levels increased from the acute to the recovery phase,
although the difference was not statistically significant. These re-
sults clearly need to be confirmed and expanded on a larger scale
[100].
9.2. The role of skin in infection
The majority of Zika virus infection is transmitted when
mosquitoes bite the skin of humans. The role of the skin in the
pathogenesis of infection carries potential significance as an entry
point into the body. Adhesion factors including AXL, Tyro3, and DC-
SIGNwere found to facilitate Zika virus entry into human skin cells.
The phosphatidylserine receptor AXL was in particular found to be
an entry receptor for the Zika virus. Dermal fibroblasts showed Zika
permissiveness using specific RNA silencing and a neutralizing
antibody. Transcription factors involved in the synthesis of the
innate immune response molecules RIG-I, MDA5 and Toll like re-
ceptor (TLR)-3 were each enhanced following Zika virus infection.
The fact that Axl tyrosine kinase is expressed by glioma cells pro-
vides a clue for its role in the pathology characterized to be asso-
ciated with Zika virus infection. More recently, a potent inhibitor
2 http://www.who.int/csr/don/15-december-2015-microcephaly-brazil/en/.
3 http://www.who.int/csr/don/8-january-2016-brazil-microcephaly/en/.
4 http://www.cdc.gov/media/releases/2016/s0315-zika-virus-travel.html.
5 http://www.cdc.gov/mmwr/volumes/65/wr/mm6502e1.htm.
6 http://www.independent.co.uk/news/world/americas/zika-virus-el-salvador-
tells-women-not-to-get-pregnant-until-2018-to-avoid-birth-defects-a6826421.
html.
7 http://www.bbc.com/news/world-latin-america-35388842.
8 http://terrance.who.int/mediacentre/presser/WHO-RUSH_Zika_virus_
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interesting candidate for the study of therapeutic options.
Interferon-stimulated genes were also enhanced. Autophagosomes
induced by Zika infection of human skin fibroblasts was associated
with increased viral replication using the autophagy inducer, Torin
1 and the autophagy inhibitor 3-methyladenine [94].
10. Prevention and treatment of Zika virus infections
10.1. Control measures
10.1.1. Insect bite precautions
Thosewho live in areaswhereAedes sppmosquitoes exist should
implement control measures such as the use of insect repellents
such as DEET, use of mosquito nets at night and wearing light
colored clothing and staying covered. The use of air-conditioning is
also potentially effective in reducing risk for mosquito bites.
10.1.2. Vector source control
Vector source control measures include removing stagnant wa-
ter and plants that contain water that are breeding grounds for
mosquitoes, spraying of areas where larvae are detected and
removal of yard debris [102]. In particular, automobile tires that tend
to accumulate stagnant water and are dark seem to be a preferred
breeding ground for mosquitoes, and should be removed. Climate
changes should also be taken into consideration when discussing
vector abundance issues. Global warming is a factor that drives
vector abundance, as may changes in humidity or rainfall. In past
studies of arbovirus circulation dynamics, rainfall negatively pre-
dicted dengue virus isolation, but positively predicted Zika virus
isolation. Temperature had opposite effects on dengue versus yellow
fever virus isolates. This is an illustration that whilewe can use other
arbovirus in predictivemodels of Zika global spread, there are subtle
nuances that may have to be considered for each viral species [103].
Education of the public regarding both insect bite precautions
and mosquito management is important as a control measure.
However, there are significant challenges in implementing
comprehensive control measures because of the need for access to
private property. Engaging homeowners to contribute to reducing
container habitats for mosquitoes on their own property plays a
significant role in the success of these control measures [104].
10.2. Public health measures
10.2.1. Travel precautions
Due to the pandemic nature of the current Zika disease phe-
nomenon, governments, including those of the United States and
the United Kingdom [105], have advised their pregnant citizens to
avoid travel to countries with documented or suspected Zika virus
epidemics.
10.2.2. Global government and regulatory reports and
recommendations regarding the Zika virus e a timeline
Since the recognition of brain defects in three offspring of
pregnant women inflicted by the Zika virus, a series of ongoing
reports and recommendations have been proposed by various
governments. On November 27th, 2015, the World Health Organi-
zation (WHO) reported 739 cases of microcephaly in Brazil. On
November 30th, 2015, PAHO reported 1248 cases in microcephaly
in Brazil.1 On December 1st, the Pan American Health Organization
(PAHO) updated its guidelines.1 http://www.paho.org/hq/index.php?option¼com_
content&view¼article&id¼11585&Itemid¼41688&lang¼en.On December 15th, the WHO reported that on December 8th,
2015, the ministry of health in Brazil provided the PAHO and WHO
with an update on the increased cases of microcephaly in Brazil.2 By
January 2nd, 2016, the number of cases of microcephaly in new-
borns in Brazil had risen to 3174.3 On Friday, January 15th, 2016, the
CDC issued a travel alert (Level 2 e practice enhanced precautions)
advising pregnant women to postpone travel to Brazil and other
countries due to reports of microcephaly and poor pregnancy
outcomes. There are 3 levels of travel advisory, Level 1 recommends
practice usual precautions and level 3 recommends the avoidance
of non-essential travel.4 On January 19th, 2016, the CDC issued
interim guidelines for pregnant females which included recom-
mendations directed at the travel and screening of pregnant
women to countries where Zika virus infection has been identified.
The guidelines outlined symptoms such as fever, rash, joint pain
and conjunctivitis that occurwithin 2weeks of travel should lead to
an evaluation of the fetus by ultrasound to identify the presence or
absence of fetal microcephaly or other abnormalities such as
intracranial calcifications [106]. The guidelines include an algo-
rithm for the management of these cases. Updated guidelines are
expected.5 On January 22nd, 2016, El Salvador issues a recom-
mendation for women of childbearing age to delay pregnancy until
2018. This came after the release of a report of 492 cases found in El
Salvador. The impact of this on population demographics and social
structure can only be imagined.6
Colombia has also issued warnings for women of child bearing
age to not get pregnant until more information is known about
spread and control.7
The CDC issued interim guidelines for testing of infants with
congenital Zika virus infection. These measures include fetal ul-
trasound review and maternal testing for Zika virus infection. Zika
virus testing is recommended for “1) infants with microcephaly or
intracranial calcifications born to women who traveled to or reside
in an areawith Zika virus transmissionwhile pregnant or 2) infants
born to mothers with positive or inconclusive test results for Zika
virus infection” [85]. The CDC recommends additional health
evaluation for infants with laboratory evidence of a possible
congenital Zika virus infection. More comprehensive guidelines are
available at the CDC website and in CDC releases. On 1st February,
2016, the World Health Organization declared Zika virus a Global
Health Emergency.8 On 3rd February, 2016 in the United States,
Florida declares a health emergency after the identification of 5
patients with Zika virus infection On 5th February, 2016, Colombia's
National Health Institute (INS) reported 3 deaths resulting from
presumed Zika virus-associated Guillain-Barre syndrome.9 On 5th
February, 2016, the WHO declared 33 countries with autochtho-
nous Zika virus infection and an additional 6 countries with local
transmission. A total of 7 countries have now reported an increased
incidence of microcephaly and/or Guillain-Barre syndrome.10
Due to the rapid developments in the global Zika virus
pandemic, new guidelines and recommendations are issued almostEmergency_committee_presser_01FEB2016.mp3?ua¼1.
9 http://news.yahoo.com/un-prods-latin-america-abortion-zika-spreads-
185202353.html.
10 http://www.who.int/emergencies/zika-virus/situation-report/en/.
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ommendations provided in the paragraphs above are only valid as
of the date of submission of this manuscript. Updated recommen-
dations are available from well known resources such as the WHO
and the CDC, as well as local or regional health departments.
10.3. Pharmacological intervention
10.3.1. The search for a vaccine
Previous vaccination against the yellow fever virus was not
sufficient to protect laboratory workers against a Zika virus infec-
tion in a case report in 1973 [107]. At the present time, no vaccine
for the Zika virus has been developed. There are plans, however,
both by the NIAID, NIH and the Brazilian government to produce an
effective vaccine but logistics dictate that it will take up to 10 years
to have such a vaccine ready for use.
10.3.2. Using genetic modifications to reduce mosquito populations
In 1991, a study was published related to the genetic selection of
mosquito strains that are resistant to flavivirus infection [108]. This
study specifically addressed the common yellow fever and the Zika
virus mosquito, A. aegypti. Identification of resistant versus sus-
ceptible phenotypes of the mosquito can lead to the isolation of
genetic differences. The artificial introduction of strains that are not
only resistant to infection but also do not transmit the virus into
mosquito breeding areas is a potential method to mitigate the
spread of infection. While this is only in concept phase, genetic
modification of wild type Aedes spp. may yet prove to be an effective
way to help curb the global spread of Zika virus.
Another strategy that has been proposed is to introduce geneti-
cally modified male mosquitoes which do not have the ability to
produce offspring intomosquito infested areas. The idea is that these
mosquitoeswill competewith indigentmosquitoes and the resultant
offspring will not be viable, thereby reducing mosquito populations.
10.3.3. Medications
The use of amotosalen combined with ultraviolet light A has
been shown to be able to inactivate Zika virus in vitro. Prior to
inactivation, Zika titers and RNA loads from the plasma spiked with
Zika virus were 6.57 log TCID50/ml and 10.25 log copies/ml
respectively. After inactivation, the RNA load was 9.51 log copies/
ml, but the inactivated plasma was unable to render cell cultures
infective. In addition, the inactivation procedure was able to
decrease the production of replicative virus after a single passage,
providing some guidance to be utilized for the discovery of anti-
viral drugs effective against Zika virus [109].
11. Challenges in the control of the Zika virus pandemic
11.1. Eliminate or minimize circulation of virus
One of the challenges of controlling the spread of Zika virus is to
control the mosquito population. Methods to be utilized have to be
environmentally safe but retain effectiveness. These include the use
of insecticides in spray form and its use in areas considered optimal
for breeding of mosquitoes such as stagnant water, ponds, and
areas where rainwater collects etc. The use of insect repellents such
as DEETand the education of residents plays a major role in curbing
mosquito populations. There are also efforts being made to intro-
duce genetically resistant strains of mosquitoes. Ironically due to
the mild nature of most Zika virus infections, the infection often
goes undetected and those capable of spreading the disease may
not appear clinically ill, and would be difficult to identify, which
provides a challenge.11.2. Diagnostic challenges
The only reliable diagnostic assay for Zika virus that has high
specificity and sensitivity is the CDC-Atlanta, USA based RT-PCR
assay. The limitation of this assay is that it is obviously only use-
ful for detection of acute illness when viremia is present. Unfor-
tunately, serologic testing for Zika IgM and IgG is confounded by the
high cross-reactivity with other flaviviruses including dengue virus
and Chikungunya. Plaque reduction neutralization tests often are
unable to resolve this cross reactivity.
11.3. The 2016 Rio Olympic games
Timing of the appearance of Zika virus infections in Brazil
coincided with a major global event that attracted millions of
tourists and increased travel to the host country, as the FIFAWorld
Cup [110]. One hypothesis that has been proposed is that it was
during the World Cup that Zika virus was brought from Africa and
the Pacific Islands into Brazil [37]. This view has provided consid-
erable concern to the organizers of the Olympic Games scheduled
to be held in Rio de Janiero in 2016. Officially, there have not been
any discussions to move or cancel the Rio Olympics, although this
has been suggested in the press, and at least one Olympic athlete
has threatened to boycott the Games.
12. Conclusions
The current Zika pandemic is a rapidly changing phenomenon
that is affecting more and more countries. Previously associated
with only mild clinical, subclinical or even asymptomatic disease,
the virus is now associated with multiple cases of neurological
damage inneonates born toZika infectedmothers, aswell as cases of
GBS in areas of Zikavirus outbreaks. Previously believed to be spread
only bymosquitoes, thus the classification as an arbovirus, it is now
known to be potentially transmissible by sexual contact or blood
transfusion. The fact that it is mostly a mild disease may actually
hinder control measures, as infected but asymptomatic individuals
may be free to spread the disease to others without being identified.
The pathogenesis of Zika virus infection, in particular the more
severe complications, is unknown. Several cellular mechanisms
may be in play, including autophagy, cytokine balance and mole-
cules such as adhesion receptors that facilitate viral entry. Inter-
feron inhibitors have been effective against Zika virus infections
in vitro, providing one alternative [94]. Since the skin is the entry
point for Zika virus infection, immune dynamics in the skin clearly
plays a role in viral entry and infection. As the Zika virus spreads,
the need for a vaccine becomes increasingly urgent. A better un-
derstanding of the pathogenesis will facilitate development of an
effective and safe vaccine. Other control measures must be imple-
mented in the meantime, including vector control and prevention
of mosquito bites. These control measures are outlined in Table 3.
Challenges for Zika virus research.
1. To clearly establish whether a link exists between the
neurologic sequelae and Zika virus infection, and if so, to
determine the risk factors (i.e., genetics and/or environ-
mental) associated with such a complication.
2. To define assays that can identify Zika virus infection of the
fetus during pregnancy.
3. Studies need to be performed to determine the molecular
signatures of the virus that are associated with virulence
and/or a link/mechanism with the neurologic complications
and the association with GBS.
4. Determine if the Zika virus isolated from its natural host in
Africa is different from the isolates from the current Zika virus.
Table 3
Management and Control measures for the Zika virus vector.
Prevention of mosquito bites
Use of house screens, window screens and mosquito nets
Use of air-conditioning
Wear light colored clothing, keep skin covered with long sleeve garments and long pants
Use insect repellent when appropriate (may not be possible for children under 3 months of age)
Source and spread control measures
Removal of stagnant water
Removal of yard debris and mosquito breeding sites
Spraying of sites where larvae present
Release of insects carrying dominant lethal genes (RIDL) [133]
Inhibiting replication via Wolbachia [133]
Disease management
Establish surveillance systems to detect the prevalence of the infection as well as potential complications [134]
Engage social media to increase awareness
Public education regarding mosquito management [104]
Accelerate research and development [134]
Regulatory reports and recommendations
Public health statements
Travel advisories
C. Chang et al. / Journal of Autoimmunity 68 (2016) 1e13 115. Define the vertebrate host range of Zika virus in more detail
to limit its spread.
6. Define methods to prevent spread of the virus via blood
transfusions or sexual contact.
7. Define the precise cell lineage that is targeted by the virus
in vivo in humans and in its natural host.
8. Determine if differences in glycosylation patterns of the en-
velope of the virus are different between different isolates.
9. Establish a pro-active Global surveillance strategy to prevent
or minimize the occurrence of an outbreak.
10. To define amore specific diagnostic test that does not require
sophisticated methodologies.
11. Produce an effective vaccine against Zika (see Table 4).Table 4
Challenges in the control of the Zika virus epidemic [135].
1. Lack of a specific diagnostic test
2. Lack of a vaccine
3. Rapid spread
4. Population demographic issues e overcrowding, poverty, poor hygiene
5. Evolution of the arboviruses
6. Increased freedom of travel
7. Mass gatherings and events (e.g. Olympics)
8. High rate of asymptomatic infected individuals (tends to mask potential carriers of the virus)Acknowledgments
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